| If this is not your name, click here. | | |
| | Contact Us | Order Now | Journals | Bookstore | Register a colleague | | |
| | | ![]() Anti-Cortisols May Offer New Hope For Retinitis Pigmentosa LAS VEGAS, NV -- November 17, 1997-- New research unveiled last week at The Second International Conference on Cortisols and Anti-Cortisols reported that retinitis pigmentosa (RP) is composed of two separate diseases -- one genetic and the other autoimmune. While the inherited genetic component has no present therapy, the auto-immune condition can be treated with anti-cortisol nutrients and drugs. Retinitis pigmentosa is a term encompassing a group of retinal degenerations, evolving from night blindness in adolescence to progressive loss of vision in adulthood. More than 400,000 Americans and millions of people worldwide suffer from RP. These new findings were disclosed in a study presented by Alfred Sapse, M.D., a leader in cortisol/anti-cortisol research and former director of ophthalmic immunology at Cedars-Sinai Medical Center in Los Angeles. "RP was previously viewed as an untreatable, solely genetic condition," Sapse said. "By uncovering its auto-immune component, we can attack the disease with a new arsenal of anti-cortisol compounds." RP's auto-immune component is believed to be associated with elevated levels of the stress hormone cortisol. Known as the fight or flight stress hormone, cortisol can throw the immune system into chaos and ravage the human body. While it was previously regarded as merely a symptom or marker of serious diseases, high levels of cortisol are now believed to be a major component of such diseases and conditions as RP, AIDS, MS, Alzheimer's, the aging process and several forms of cancer. According to Sapse, RP can be treated initially with a cocktail of anti-cortisol nutritional compounds including vitamin A, zinc, ginkgo biloba and acetyl-L-carnitine, followed by treatment using anti-cortisol/steroidogenesis inhibitor drugs. The key to treatment of RP with anti-cortisol drugs is the ability to accurately measure when cortisol levels are elevated. In this regard, Sapse has introduced a new 24-hour circadian cortisol chart to accurately measure levels of the hormone in RP patients.
|